Helping you understand the evolving treatment landscape in Breast Cancer

HER2+ Metastatic Breast Cancer

Breast  cancer is a critical health issue affecting millions of women worldwide. October is Breast Cancer Awareness Month, dedicated to raising awareness, sharing experiences, and promoting research and prevention efforts. 

For almost 40 years, more and more stakeholders have been working to make October the month of breast cancer awareness. This period is an opportunity to communicate, exchange, and share experiences about breast cancer among health professionals. It is essential to discuss early detection, treatments, and patient experiences to improve outcomes and support people globally.

Understanding the epidemiology of breast cancer is crucial for awareness, prevention and treatment efforts. With 2.3 million new cases diagnosed per year1, Breast cancer is the second most common type of cancer worldwide, after Lung, and first in Europe. Among women, breast cancer is the most common type of cancer, with 666K deaths each year worldwide1, however, thanks to early detection, improvement in treatments and treatment management, breast cancer mortality is reducing at a rate of 2-4% per year2

SOCIAL MEDIA IMPACT of the EHA 2024 Hybrid Congress

Digital, hemato-oncology, Social Media Listening, Oncology

The EHA 2024 (European Hematogoly Association) Hybrid Congress took place from June 13th to June...

SOCIAL MEDIA IMPACT of ASCO 2024

Digital, hemato-oncology, Social Media Listening, Oncology

The 2024 ASCO annual meeting took place from May 31st  to June 4th, 2024, in Chicago, Il, USA. This...

What does MM mean to me? A special interview with DR. Christine MAÏ - APLUSA

AplusA News, Healthcare Industry, Syndicated Studies, hematology, MMActionMonth, Multiple Myeloma

Myeloma Action Month is held every year for the whole month of March to encourage individuals and...

Post ASH 23 webinar with Dr. Blin | Focus on DLBCL session

AplusA News, hemato-oncology, ASH, congress

Discover the transcription of our Post-ASH 23 webinar with Dr. BLIN, provides comprehensive...

Post ASH 23 webinar with Dr. Blin | Focus on MDS session

hemato-oncology, ASH, congress, MDS

Discover the transcription of our Post-ASH 23 webinar with Dr. BLIN with Dr. BLIN, provides...

Post ASH 23 webinar with Dr. Blin | Focus on MM session

AplusA News, hemato-oncology, Syndicated Studies, ASH, hematology, congress

Discover the transcription of our Post-ASH 23 webinar with Dr. BLIN, provides comprehensive...

Post ASH 23 webinar with Dr. Blin | Focus on AML session

AplusA News, hemato-oncology, ASH, hematology, congress

Discover the transcription of our Post-ASH 23 webinar with Dr. BLIN, providing comprehensive...

Social Media Impact of the 65th ASH annual meeting 2023

Digital, hemato-oncology, Social Media Listening, Oncology

The 65th ASH annual meeting and exposition took place on December 09-12, 2023, in San Diego,...

Etude d'impact sur la vaccination antigrippale pour Sanofi

vaccine

Notre étude APLUSA révèle l’impact qu’aurait une recommandation des autorités en faveur d’un vaccin...